480 related articles for article (PubMed ID: 21810256)
1. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
[TBL] [Abstract][Full Text] [Related]
3. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
[TBL] [Abstract][Full Text] [Related]
5. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
6. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
[TBL] [Abstract][Full Text] [Related]
9. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.
Jovel IT; Mejía RE; Banegas E; Piedade R; Alger J; Fontecha G; Ferreira PE; Veiga MI; Enamorado IG; Bjorkman A; Ursing J
Malar J; 2011 Dec; 10():376. PubMed ID: 22183028
[TBL] [Abstract][Full Text] [Related]
11. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
Narang G; Jakhan J; Tamang S; Yadav K; Singh V
Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
[TBL] [Abstract][Full Text] [Related]
13. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
Mubjer RA; Adeel AA; Chance ML; Hassan AA
Malar J; 2011 Aug; 10():245. PubMed ID: 21854642
[TBL] [Abstract][Full Text] [Related]
15. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
[TBL] [Abstract][Full Text] [Related]
16. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
Kar NP; Chauhan K; Nanda N; Kumar A; Carlton JM; Das A
Infect Genet Evol; 2016 Jul; 41():47-55. PubMed ID: 26988711
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Barnadas C; Tichit M; Bouchier C; Ratsimbasoa A; Randrianasolo L; Raherinjafy R; Jahevitra M; Picot S; Ménard D
Malar J; 2008 Feb; 7():35. PubMed ID: 18302746
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]